0% found this document useful (0 votes)
182 views13 pages

Biopharm Notes by ANEEZA AMJAD

The document provides an overview of biopharmaceutics, focusing on pharmacokinetic models, including compartment models and their classifications. It discusses key concepts such as bioavailability, drug absorption, elimination processes, and the impact of protein binding on drug kinetics. Additionally, it covers methods for determining bioavailability and the significance of the first-pass effect in drug metabolism.

Uploaded by

Ali Hussnain
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
182 views13 pages

Biopharm Notes by ANEEZA AMJAD

The document provides an overview of biopharmaceutics, focusing on pharmacokinetic models, including compartment models and their classifications. It discusses key concepts such as bioavailability, drug absorption, elimination processes, and the impact of protein binding on drug kinetics. Additionally, it covers methods for determining bioavailability and the significance of the first-pass effect in drug metabolism.

Uploaded by

Ali Hussnain
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

Short Notes of Biopharmaceutics for

PPSC
BY
ANEEZA AMJAD
PPSC BATCH 442/2019,
MERIT NO: 09

Pharmacokinetic models -------


a.Compartment model, b.non-compartment model, c. physiological models

Compartment models
Body composed of different compartments/tissues with similar blood flow and drug
affinity

Types of compartment model

a. Mammillary model b.caternary models c. open models d. closed


model

1)mammillary model--- consist of one or more peripheral tissue attached with central
tissue
Central compartment is blood
One compartment model

One Compartments open model classification


a. i/v one compartment open model b. extravascular one compartment open model

1) iv one compartment open model


 Only Elimination ----K1
 the first order process with first order rate constant
 Parameters are 3---- elimination half life, elimination ate constant, clearance
2) extravascular one compartment open model
 Absorption + elimination
 First order + zero order process
 Parameters --- clearance, t1/2, tmax, cmax, ka, ke, f( fraction of dose)

Two compartment open model


Consist of 2 compartments

a. iv two compartment open model b. extravascular two compartment open model

1) iv two compartment model


 Absorption + elimination
 Parameters –ka, ke, t1/2, clearance, tmax, cmax

2) extravascular two compartment open model


 Absorption + distribution + elimination
 Parameters –ka,ke, vd, t1/2, clearance, tmax, cmax,
Determination of absorption rate
a. residual method b. wagner nelson method
Slope-------- -Ke/2.303

Clearance----it relates plasma drug conc. With rate of elimination, dx/dt/c

Half life---- time for decline of l conc. To 50% of original conc. T1/2= 0.693/k

Steady state conc.( Css)------conc. Of drug plasma reached at constant


value, straight line graph

Css= infusion rate/clearance=-KeT/2.303

Shorter half life sooner steady conc., 90% for therapeutic dose

Urinary excretion models ----determine excretion rate constant and


elimination rate constant

Parameters ----- AUC, Emax, Tmax, Cl, Ke, Cmax

BCS biopharmaceutical classification system


Solubility permeability

Class1 high high complete bioavailability, immediate relase


drugs

Class 2 low high bioavailability is controlled by dosage form

Class3 high low bioavailability incomplete

Class4 low low difficult to form


Bioavailability – the rate and extent of therapeutic active drug that reach the systemic
circulation and available at the site of action. AUC/Dose

Absolute bioavailability—the systemic bioavailability of oral compared with iv—

F= AUC extra / AUC iv x Dose iv/Dose extravascular

Relative bioavailability—the systemic bioavailability of oral compared with standard..

F = AUC extra1/AUC extra2 x dose extra2/dose extra1

Method of bioavailability determination —


a)pharmacokinetic method(indirect) ----blood analysis, urinary excretion method

b)pharmacodynamic method (direct)-- acute pharmacological response, therapeutic


method

AUC determination--- Trapezoidal method---AUC= ½(c1+c2)(t2-t1)+1/2(c2+c3)(t3-


t2)……

Bioequivalence --pharmaceutical equivalent or alternative products that display


comparable bioavailability

Pharmaceutical alternatives ---drug that contain same therapeutic moiety


but as different salts,esters etc. Ex.tetracycline Ph. And teteacycline Hcl

Pharmaceutical equivalent—drug products with same active ingredient


and same salts, dosage form but differ in shape , packaging, release mechanism. Ex.
Chlordiazepoxide hcl 5mg cap

Therapeutic alternatives ---drug with different active ingredient indicated for


same therapeutic or clinical objective. Ex. Cimetidine and rantidine

Therapeutic equivalent---drug product that are pharmaceutical equivalent


and same clinical object. Ex.valium and vintage (same generic )

Therapeutic substitution —the process of dispensing a therapeutic


alternative instead of prescribed drug ex. Amoxicillin instead of ampicillin

Dissolution rate--- The dissolution rate is a measure of the actual release rate
of the compound at the given particle size etc. in an aqueous media
Dissolution apparatus—
1.rotating basket apparatus

2.peddle apparatus

3.reciprocating cylinder apparatus

4.flow through cell

5.peddle over disk

6.rotating cylinder

7.reciprocating disk apparatus

Noyes whitney equation for dissolution rate; dc/dt=k(Cs-Cb)


Cs:conc.of solution at solid surface Cb: conc. Of bulk

General equation of straight line; y=mx+b slope=y2-y1/x2-x1

m=slope, b=y-intercept , y=y-axix parameter, x=x-axis parameter

Volume of distribution---hypothetical volume of body into which drug is


distributed

Vd=dose/Cp

Rate of reaction —no. of drug molecules converted into products


change in conc./change in time

order of reaction—no. of molecules whose conc. Determine rate of reaction


zero order reaction—independent of conc.

First order reaction—depends upon conc.

Protein binding—drug interact with plasma or tissue protein and form drug-
protein complex.

1.plasma protein binding-Ex albumin, globulin, fibrinogen, thrombin

2.tissue protein binding---lipoproteins

Irreversible Protein Binding= result of chemical reaction, attached strongly to drug


Reversible Protein Binding= drug binds the protein with weaker bond. It includes
Albumin, Globulin, alpha 1 glycoacid protein.

Acidic drugs bind to ALBUMIN such as Penicillins, Phenylbutazone, salicylate etc.

basic drugs bind to a1-acid glycoprotein also known as Orosomucoid. Example


Propranolol, lidocaine, imipramine etc.

globulins responsible for transportation of endogenous substances such as


corticosteroid.

Kinetics of Protein binding


r=moles of drug bound / total moles of protein

r= (PD) / (PD) +(P)

Linear pharmacokinetics non-linear pharmacokinetics


1.dose independent dose independent
2.ADME follow 1st order Saturable
3.AUC directly proportional to dose AUC is disproportional to dose
4.PK parameters constant PK parameters dose dependent
5.conc vs time superimposeable not superimposeable

Michelis menton equation for non-linear PK;


v=Vmax(S)/Km+(S)

V=rate of metabolism,

Vmax=max. rate of met.

S=substrate conc.

Km=mechalis constant

IVIVC in-vitro in-vivo correlation—relationship b/w in-vitro property


and in-vivo response

Drug Absorption
Passage of drug across cell membrane

1)Passive Diffusion: Spontaneous diffusion from area of higher conc. To lower conc.
No external energy required

Fick’s law:Dq/dt=DAK/h(C GI-CP)


Dq/dt=rate of diffusion, D=diffusion co-efficient

K= lipid-water partition co-efficient A=surface area

H=memb. Thickness CGI -CP=difference b/w conc.

2)Active Diffusion: Carrier mediated transmembrane process from region of low conc.
To high conc. Energy consuming process

3)Facilitated diffusion: carrier mediated diffusion move along conc. Gradient. It is


saturable.

Vesicular transport=processof engulfing particles by the cell.


1)Pinocytosis: engulfment of small solutes

2)Phagocytosis:engulfment of larger paarticles

3)Endocytosis: process of moving specific molecules into the cell.

4)Exocytosis: process of moving specific molecules out of the cell.E.g.transport of


Insulin

5)Transcytosis:process by which various macromolecules are transported into the


interior of cell.

Drug Elimination and Hepatic Clearance


Drugs eliminate from body involves the proceessof both metabolism

1)Biotransformation=enzymatic conversion of a drug to a metabolite. E.g.


Theophylline, Phenytoin, Acetaminophen etc. Follow the Michalis-Menten equation

Michelis menton equation for non-linear PK;


v=Vmax(S)/Km+(S)

V=rate of metabolism,

Vmax=max. rate of metabolism.

S=substrate conc.

Km=mechalis constant

Relation of Rate of metabolism to Drug conc. Is non-linear and curve is hyperbolic.

 Phase I Reaction: occur first and introduce a functional group on drug molecule.
Oxidation: Addition of oxygen.Aromatic Hydroxylation, Deamination, Sulfoxidation, N-
Hydroxylation

Reduction: Addition of Hydrogen. Azoreduction, Nitro-reduction, Alcohol


dehydrogenase

Hydrolysis: addition of H2O and cleavage of bond. Ester hydrolysis, Amide hydrolysis

 Phase II Reaction/ Conjugation: once a polar constitute is placed, conjugation


reaction may occur. Involve conjugating agents ,High energy intermediates
formed which combined with drug to form conjugate.

Conjugation Conjugating agent High-energy Functional groups


reaction intermediate combined with
Gulcuronidation Glucuronic acid UDPGA _OH, _COOH
Sulfation Sulfuric acid PAPS _NH2, _SH
Acetylation Acetyl Co A Acetyl Co A _OH, _NH2
Methylation CH3 S-adenosyl _OH, _NH2
methionine
Glutathione Glutathione Epoxide, Epoxide

2)Renal Excretion=drug disposition by the kidney include glomerular filtration,


active tubular secretion etc.

Hepatic Clearance=volume of blood that perfuse the liver which is cleared of drug
per unit time.

Clh=CIT+CIR CIh=Hepatic clearance, CIT=total clearance CIR= renal


clearance

FIRST-PASS EFFECT=Rapid metabolism of an orally administered drug before


reaching the general circulation.

Absolute Bioavailability=F= AUC oral / Doral


AUC iv / D iv
 Drugs 100% absorbed and stable in GIT, Absolute Bioavailability=F=1
 Drugs undergo first-pass effect, F>1 EXAMPLE; Nitroglycerin, Morphine

Multiple-Drug Oral Dose Regimen


Drug conc. After multiple oral dose

Cav=FD0/VDKᴫ
ᴫ=dosage interval, F=fraction of dose absorbed
Cmax=FD0 ⌠1/1-e-kᴫ ⌡e-ktp
VD

Cmax=kaFD0 ⌠1/1-e-kᴫ ⌡e-kt


VD (ka-k)

You might also like